May 10, 2016 — Cardiovascular magnetic resonance (CMR) is a stronger predictor of risk for major adverse cardiovascular ...
Nuclear Imaging
Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
May 5, 2016 — Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to ...
April 21, 2016 – UltraSPECT Inc. announced the 10th anniversary of the U.S. Food and Drug Administration (FDA) approval ...
April 5, 2016 — New research shows individuals with a greater degree of activity in the stress center of the brain also ...
January 27, 2016 — UltraSPECT Inc. has marked the 450th U.S. installation of its low-dose image processing technology ...
January 21, 2016 — Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...
November 16, 2015 — GE Healthcare’s Molecular Imaging business will showcase the Discovery IQ positron emission ...
September 23, 2015 — New research describes a method, tested in rats, that may someday allow healthcare providers to ...
September 17, 2015 — At the National Nuclear Security Administration’s (NNSA) 2015 Mo-99 Topical Meeting, Novation ...
September 16, 2015 — A novel radiopharmaceutical probe developed at Massachusetts General Hospital (MGH) has the ...
September 11, 2015 — Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and ...
September 11, 2015 — Westinghouse Electric Company and NorthStar Medical Radioisotopes announced a memorandum of ...
August 31, 2015 — NorthStar Medical Radioisotopes LLC has received approval to begin routine production of molybdenum-99 ...
July 30, 2015 — Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of Tc9 ...